Non-Small-Cell Lung Carcinoma [clinicaltrials_resource:8c0a3ac074212c52a08fc4ec2b3accda]
clinicaltrials:NCT00037817ABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic Cancer [clinicaltrials:NCT00056537]Study Evaluating EKB-569 in Advanced Non-Small Cell Lung Cancer [clinicaltrials:NCT00067548]Iressa Versus Docetaxel (Taxotere) [clinicaltrials:NCT00076388]Study of ILX651 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Carcinoma [clinicaltrials:NCT00078455]Maintenance ZD1839 (IRESSA®) Following Completion of Front Line, Platinum-Based, Double Chemotherapy in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer [clinicaltrials:NCT00090675]A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer) [clinicaltrials:NCT00095225]Study of the Feasibility to Derive Vaccine From Tumor Tissue in Patients With Non-Small Cell Lung Cancer [clinicaltrials:NCT00098085]clinicaltrials:NCT00098254clinicaltrials:NCT00100932A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00102505]Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer. [clinicaltrials:NCT00105092]Celecoxib Treatment for Lung Cancer [clinicaltrials:NCT00108186]A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00112060]clinicaltrials:NCT00112294Study of Gemcitabine/Platinum +/- Cetuximab as First-Line Treatment for Patients With Advanced/Metastatic Non-Small Cell Lung Cancer [clinicaltrials:NCT00112346]Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer [clinicaltrials:NCT00129844]clinicaltrials:NCT00132665Positron Emission Tomography (PET) Imaging in Stage III Non-small Cell Lung Cancer (PET START Trial) [clinicaltrials:NCT00136864]clinicaltrials:NCT00137800Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy. [clinicaltrials:NCT00148395]A Phase I Study of Cetuximab in Combination With Gefitinib in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer [clinicaltrials:NCT00162318]HI-CHART:Feasibility of High-Dose Accelerated Conformal Radiotherapy [clinicaltrials:NCT00181506]Safety Study of Individualised Radiation Dose Determination for Lung Cancer Patients. [clinicaltrials:NCT00181545]Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer. [clinicaltrials:NCT00191620]Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up [clinicaltrials:NCT00198341]clinicaltrials:NCT00201825clinicaltrials:NCT00243347Phase II Iressa Versus Vinorelbine (INVITE) [clinicaltrials:NCT00256711]LIFE-Lung Bronchoscopy in Patients at Risk for Developing Lung Cancer [clinicaltrials:NCT00260598]Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients [clinicaltrials:NCT00271323]Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20) [clinicaltrials:NCT00310232]Concurrent Helical Tomotherapy With Chemotherapy in Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC) [clinicaltrials:NCT00379717]clinicaltrials:NCT00404924clinicaltrials:NCT00444015Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors [clinicaltrials:NCT00511576]clinicaltrials:NCT00600821Study to Evaluate Erlotinib With or Without SNDX-275 in the Treatment of Patients With Advanced NSCLC [clinicaltrials:NCT00602030]Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors [clinicaltrials:NCT00910676]clinicaltrials:NCT00915005
condition [clinicaltrials_vocabulary:condition]
Non-Small-Cell Lung Carcinoma [clinicaltrials_resource:8c0a3ac074212c52a08fc4ec2b3accda]
Bio2RDF identifier
8c0a3ac074212c52a08fc4ec2b3accda
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:8c0a3ac074212c52a08fc4ec2b3accda
identifier
clinicaltrials_resource:8c0a3ac074212c52a08fc4ec2b3accda
title
Non-Small-Cell Lung Carcinoma
@en
label
Non-Small-Cell Lung Carcinoma [clinicaltrials_resource:8c0a3ac074212c52a08fc4ec2b3accda]
@en